January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
14hon MSN
Drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a share-price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback